# Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

> **NCT07015892** · PHASE3 · RECRUITING · sponsor: **Instituto de Investigación Biomédica de Salamanca** · enrollment: 300 (estimated)

## Conditions studied

- Small Cell Lung Carcinoma

## Interventions

- **RADIATION:** Thoracic Radiotherapy 45 Gy BID
- **RADIATION:** Thoracic Radiotherapy 60 Gy BID
- **RADIATION:** Thoracic Radiotherapy SIB 45-54 Gy BID

## Key facts

- **NCT ID:** NCT07015892
- **Lead sponsor:** Instituto de Investigación Biomédica de Salamanca
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07015892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07015892, "Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07015892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*